Eliglustat Tartrate is a potent glucosylceramide synthase inhibitor indicated for the treatment of mild to moderate type 1 Gaucher disease in adults by reducing the accumulation of glucosylceramide in… Read more
Eliglustat Tartrate is a potent glucosylceramide synthase inhibitor indicated for the treatment of mild to moderate type 1 Gaucher disease in adults by reducing the accumulation of glucosylceramide in cells. The category includes high-quality reference standards for Eliglustat Tartrate, alongside related impurities and stable isotope labelled compounds essential for rigorous analytical testing. Laboratories utilize these materials for impurity profiling, method development, and validation procedures to ensure the accuracy of chromatographic separation and mass spectrometry techniques. By providing precise, identifiable standards, these compounds support the comprehensive quality control required during pharmaceutical manufacturing and stability testing. Whether performing routine batch release analysis or complex quantitative assessments, these reference materials enable chemists to reliably verify drug identity and purity levels across various research and regulatory applications.